IdentifAi Genetics is a biotech company based a on long academic research. Our technology enables actionable clinical insights based on cfDNA analysis.
Liquid Biopsy Vision
Our vision is to use our fragmentomix unique capabilities to enable a one-stop-shop test to detect, monitor and improve cancer treatment.
Activity In The Consortium
IdentifAi will use its technology to provide clean data from patients’ DNA, focusing on fragmantomix insights, that in correlation with other sources of data will enable developing new diagnostics solutions.